Timothy Back

5.6k total citations
59 papers, 2.7k citations indexed

About

Timothy Back is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Timothy Back has authored 59 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 24 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Timothy Back's work include Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (19 papers) and CAR-T cell therapy research (8 papers). Timothy Back is often cited by papers focused on Immunotherapy and Immune Responses (21 papers), Immune Cell Function and Interaction (19 papers) and CAR-T cell therapy research (8 papers). Timothy Back collaborates with scholars based in United States, India and Japan. Timothy Back's co-authors include Robert H. Wiltrout, Jon M. Wigginton, Kristin L. Komschlies, Thomas J. Sayers, Jonathan M. Weiss, Jeffrey Subleski, John R. Ortaldo, Julie A. Hixon, Jimmy K. Stauffer and Michael J. Brunda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Timothy Back

59 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timothy Back United States	32	1.6k	1.1k	788	311	262	59	2.7k
Anna Maria Orengo Italy	29	2.3k 1.4×	1.0k 1.0×	754 1.0×	351 1.1×	123 0.5×	63	3.5k
Giulia Parisi Italy	21	1.4k 0.9×	1.5k 1.5×	1.1k 1.4×	268 0.9×	136 0.5×	35	2.8k
Yannick Jacques France	34	2.7k 1.7×	1.4k 1.3×	1.0k 1.3×	159 0.5×	225 0.9×	93	4.2k
Adrienne Luoma United States	20	1.8k 1.1×	1.4k 1.3×	902 1.1×	205 0.7×	190 0.7×	25	3.0k
Hong Ji China	21	1.9k 1.1×	930 0.9×	1.8k 2.3×	300 1.0×	125 0.5×	35	4.1k
Masuo Hosokawa Japan	30	779 0.5×	854 0.8×	1.2k 1.5×	657 2.1×	215 0.8×	88	2.7k
Laura S. Angelo United States	19	696 0.4×	985 0.9×	981 1.2×	294 0.9×	125 0.5×	29	2.1k
Sam T. Hwang United States	24	1.7k 1.0×	1.5k 1.4×	1.2k 1.5×	157 0.5×	197 0.8×	43	3.2k
Koh Yamamoto Japan	14	1.3k 0.8×	1.1k 1.0×	629 0.8×	175 0.6×	133 0.5×	32	2.2k
Cheryl Nickerson‐Nutter United States	28	1.8k 1.1×	572 0.5×	774 1.0×	232 0.7×	142 0.5×	44	3.2k

Countries citing papers authored by Timothy Back

Since Specialization

Citations

This map shows the geographic impact of Timothy Back's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Back with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Back more than expected).

Fields of papers citing papers by Timothy Back

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Back. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Back. The network helps show where Timothy Back may publish in the future.

Co-authorship network of co-authors of Timothy Back

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Back. A scholar is included among the top collaborators of Timothy Back based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Back. Timothy Back is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, De, Xiaoqing Li, Jia Liu, et al.. (2022). Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function. Cell Reports. 38(2). 110090–110090. 69 indexed citations

Tewary, Poonam, Alan D. Brooks, Ya-Ming Xu, et al.. (2021). Small-Molecule Natural Product Physachenolide C Potentiates Immunotherapy Efficacy by Targeting BET Proteins. Cancer Research. 81(12). 3374–3386. 12 indexed citations

Yang, De, Xiaoqing Li, Jia Liu, et al.. (2020). Alpha-synuclein (αS) functions as an alarmin to promote inflammatory and immune responses by activating dendritic cells and macrophages. The Journal of Immunology. 204(1_Supplement). 160.7–160.7. 1 indexed citations

Jiang, Qun, Jonathan M. Weiss, Timothy Back, et al.. (2011). mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment. Cancer Research. 71(12). 4074–4084. 71 indexed citations

Stauffer, Jimmy K., Anthony J. Scarzello, Jesper B. Andersen, et al.. (2011). Coactivation of AKT and β-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors. Cancer Research. 71(7). 2718–2727. 68 indexed citations

Hussain, S. Perwez, Peijun He, Jeffrey Subleski, et al.. (2008). Nitric Oxide Is a Key Component in Inflammation-Accelerated Tumorigenesis. Cancer Research. 68(17). 7130–7136. 85 indexed citations

Khan, Tahira, Jimmy K. Stauffer, R. H. Williams, et al.. (2006). Proteasome Inhibition to Maximize the Apoptotic Potential of Cytokine Therapy for Murine Neuroblastoma Tumors. The Journal of Immunology. 176(10). 6302–6312. 30 indexed citations

Yazawa, Hiroyuki, Takaya Murakami, Timothy Back, et al.. (2006). Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors. Cancer Gene Therapy. 13(11). 993–1001. 18 indexed citations

Salcedo, Rosalba, Jimmy K. Stauffer, Timothy Back, et al.. (2004). IL-27 Mediates Complete Regression of Orthotopic Primary and Metastatic Murine Neuroblastoma Tumors: Role for CD8+ T Cells. The Journal of Immunology. 173(12). 7170–7182. 132 indexed citations

10.

Murphy, William J., Timothy Back, Julie A. Hixon, et al.. (2003). Synergistic Anti-Tumor Responses After Administration of Agonistic Antibodies to CD40 and IL-2: Coordination of Dendritic and CD8+ Cell Responses. The Journal of Immunology. 170(5). 2727–2733. 84 indexed citations

11.

Seki, Naoko, Alan D. Brooks, Clive R.D. Carter, et al.. (2002). Tumor-Specific CTL Kill Murine Renal Cancer Cells Using Both Perforin and Fas Ligand-Mediated Lysis In Vitro, But Cause Tumor Regression In Vivo in the Absence of Perforin. The Journal of Immunology. 168(7). 3484–3492. 111 indexed citations

12.

Wigginton, Jon M., Jong‐Keuk Lee, T A Wiltrout, et al.. (2002). Synergistic Engagement of an Ineffective Endogenous Anti-Tumor Immune Response and Induction of IFN-γ and Fas-Ligand-Dependent Tumor Eradication by Combined Administration of IL-18 and IL-2. The Journal of Immunology. 169(8). 4467–4474. 60 indexed citations

13.

Wigginton, Jon M., Jong‐Wook Park, Howard A. Young, et al.. (2001). Complete Regression of Established Spontaneous Mammary Carcinoma and the Therapeutic Prevention of Genetically Programmed Neoplastic Transition by IL-12/Pulse IL-2: Induction of Local T Cell Infiltration, Fas/Fas Ligand Gene Expression, and Mammary Epithelial Apoptosis,. The Journal of Immunology. 166(2). 1156–1168. 42 indexed citations

14.

Lee, Jong‐Keuk, Thomas J. Sayers, Alan D. Brooks, et al.. (2000). IFN-γ-Dependent Delay of In Vivo Tumor Progression by Fas Overexpression on Murine Renal Cancer Cells. The Journal of Immunology. 164(1). 231–239. 61 indexed citations

15.

Ito, Daisuke, Timothy Back, Alexander N. Shakhov, Robert H. Wiltrout, & Sergei A. Nedospasov. (1999). Mice with a Targeted Mutation in Lymphotoxin-α Exhibit Enhanced Tumor Growth and Metastasis: Impaired NK Cell Development and Recruitment. The Journal of Immunology. 163(5). 2809–2815. 47 indexed citations

16.

Wigginton, Jon M., Douglas B. Kuhns, Timothy Back, et al.. (1996). Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2.. PubMed. 56(5). 1131–6. 54 indexed citations

17.

Murphy, W J, Timothy Back, Kevin C. Conlon, et al.. (1993). Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts.. Journal of Clinical Investigation. 92(4). 1918–1924. 38 indexed citations

18.

Futami, Hitoyasu, et al.. (1991). In vivo distribution and cytokine gene expression by enriched mouse LAK effector cells. Biotherapy. 3(3). 219–232. 1 indexed citations

19.

Wiltrout, Robert H., et al.. (1988). Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer.. The Journal of Immunology. 140(9). 3261–3265. 55 indexed citations

20.

Ågren, Anders & Timothy Back. (1973). Complex formation between macromolecules and drugs. 8. Binding of saccharine, N-methyl saccharine, and the diuretic drugs hydroflumethiazide and bendroflumethiazide to human serum albumin.. PubMed. 10(3). 223–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact